Produktname:1-Bromo-4-chloroimidazo[1,2-a]quinoxaline
IUPAC Name:1-bromo-4-chloroimidazo[1,2-a]quinoxaline
- CAS：1254196-52-5
- Molekulare Formel：C10H5BrClN3
- Reinheit：95%
- Katalognummer：CM221304
- Molekulargewicht：282.53
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:1254196-52-5
- Molekulare Formel:C10H5BrClN3
- Schmelzpunkt:-
- SMILES-Code:ClC1=NC2=C(N3C1=NC=C3Br)C=CC=C2
- Dichte:
- Katalognummer:CM221304
- Molekulargewicht:282.53
- Siedepunkt:
- Mdl-Nr.:MFCD18711463
- Lagerung:
Category Infos
- Quinoxalines
- Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.
- Imidazopyrazines
- In addition to the nitrogen-based heterocycles presented so far, a number of others nitrogen-based scaffolds have also been reported as promising agents for GBM treatment, including pyrazolo-triazole, imidazotetrazine, piperidine, purine, imidazopyrazine, pyrazole, triazole among others.
Suche 
+86 21 5895 0110 
